Clinical Trial Update: Safety and Efficacy of Anti-Pandemic H1N1 Vaccination in Rheumatic Diseases [Phase 4]

View source ↗

Summary

Phase 4 study assessing the safety and efficacy of an H1N1 vaccine in patients with rheumatic diseases. The current status of the trial is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Antiphospholipid Syndrome
• Dermatomyositis
• Mixed Connective Tissue Disease
• Rheumatoid Arthritis
• Sjögren Syndrome
• Spondyloarthritis
• Systemic Lupus Erythematosus
• Systemic Sclerosis

Drugs mentioned

• H1N1 vaccine

Snippet

Sponsor: University of Sao Paulo | Conditions: Rheumatoid Arthritis, Spondyloarthritis | Phase 4 | Status: UNKNOWN